当前位置: 首页 > 期刊 > 《中国现代医生》 > 20202
编号:13516821
RON及其致癌型变异体RONΔ160在乳腺癌中的表达(5)
http://www.100md.com 2020年1月15日 《中国现代医生》 20202
     [17] Chakedis J,French R,Babicky M,et al. A novel protein isoform of the RON tyrosine kinas receptor transforms human pancreatic duct epithelial cells[J]. Oncogene,2016, 35(25):3249-3259.

    [18] Wang MH,Kurtz AL,Chen YQ.Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells[J]. Carcinogenesis,2000, 21:1507-1512.

    [19] Zhou YQ,He C,Chen YQ,et al. Altered expression of the RON receptor tyrosine kinase in human colorectal adenocarcinomas:Generation of different splicing variants and their oncogenic potential[J]. Oncogene,2003, 22:186-197.

    [20] Ronsin C,Muscatelli F,Mattei MG,et al. A novel putative receptor protein tyrosine kinase of the met family[J].Oncogene,1993,8:1195-1202.

    [21] Zhang K,Zhou YQ,Yao HP,et al. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells[J]. Int J Oncol,2010;36:255-264.

    (收稿日期:2019-07-09), 百拇医药(许国富 黄国强)
上一页1 2 3 4 5